Fill Finish Manufacturing Market Size, COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Fill Finish Manufacturing Market Size will gain appreciable gains during the period 2021 to 2027 on account of the rising technological developments. The increasing need for sterile products has made way for the higher adoption of prefilled syringes to facilitate parenteral dosage forms.
 

The growing advancements in medical packaging across the pharmaceutical sector and the influx of advanced biologics are other potential contributors to the fill finish manufacturing market expansion.
 

The consumables segment is expected to capture a substantial revenue share owing to the higher need for disposable packaging in biologics. Medical consumables are mainly necessary supplies employed in health systems to offer care across hospitals or surgical environments. The ongoing COVID-19 crisis has also considerably boosted the requirement for consumables. The surging penetration of vials in lyophilization and the optimum acceptance of prefilled syringes will act as significant prospects for the segment expansion.
 

The fill finish manufacturing demand in contract manufacturing organizations (CRO) will grow through 2027 with the higher instances of outsourcing from small-sized biopharma firms. The mount in the number of novel industry players in the biologics manufacturing arena will signify the end-user segment spurt.
 

Pharmaceutical & biopharmaceutical companies will witness lucrative growth due to the increasing government support to curb the COVID-19 infection spread. To meet the requirements of highly heat-sensitive materials, biopharma firms are increasingly developing protein-based therapeutics. The surging demand for vaccines and numerous drugs for the treatment of the virus will also contribute to the industry growth.
 

Europe fill finish manufacturing market size is set to attain momentum led by the higher prevalence of chronic disorders in the region. The strong presence of some of the major industry players will also drive the regional growth.
 

Asia Pacific is anticipated to collect a prominent fill finish manufacturing market share given the rising advancements in the biopharmaceutical sector coupled with the booming patient pool. The surging government efforts and significant rise in healthcare R&D infrastructure activities will further sway the market progression.
 

Leading fill finish manufacturing industry players include Optima, Piramal Pharma Solutions, West Pharmaceutical Services, Inc., Dickinson and Company, Schott AG (Carl-Zeiss-Stiftung), Robert Bosch GmbH (Robert Bosch Stiftung GmbH), Nipro Medical Corporation (Nipro), Groninger, Gerresheimer AG, IMA, and Becton.
 

These firms are striving towards several targeted marketing efforts, like partnerships, production expansions, innovations, acquisitions, and investments in order to amplify their geographical and competitive footprint.
 

For instance, in January 2021, Piramal Pharma Solutions (PPS) announced its collaboration with Canadian biopharma firm, Theratechnologies to provide GMP (good manufacturing practice) production of sterile fill/finish drug products for supporting its first-in-human clinical developmental offerings.
 

In another instance, in December 2020, Becton, Dickinson and Company invested close to USD 1.2 billion over a 4 year period to proliferate and upgrade its manufacturing capacity as well as technology for PFS (pre-fillable syringes) and ADDS (advanced drug delivery systems) in its six global manufacturing regions in Europe.
 

Effect of the COVID-19 pandemic on fill finish manufacturing market trends

The economic upheaval prompted by the COVID-19 crisis massively impacted millions of businesses across the globe as it laid unimaginable barriers to trade and supply chains. However, it acted as a potential booster for the industry considering its growing penetration across the pharma and biopharma sectors for the development of various vaccines and treatment drugs in response to the virus. For instance, in March 2021, Baxter BioPharma Solutions signed an agreement with Moderna for the Fill/Finish Manufacturing of the latter’s COVID-19 vaccine in the U.S.  
 

The fill finish manufacturing market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product

• Consumables
  • Prefilled Syringes
  • Vials
  • Cartridges
  • Others
• Instruments

Market, By Application

• Solids
• Semi-solids
• Liquids

Market, By End users

• Contract Manufacturing Organizations
• Biopharma Companies
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Qatar

What Information does this report contain?